The Neuro’s drug discovery initiative supports research by developing assays shared with the scientific community
In the past 40 years, the model of drug discovery used by the pharmaceutical industry, while proving successful for some applications, has produced very little for neurodegenerative diseases.
“We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”“Take Parkinson’s disease, for instance: there have been zero new disease modifying medications developed in the last 40 years, despite hundreds of millions of dollars being invested in research,” says Dr. Edward Fon, whose lab focuses on molecular and cellular research into Parkinson’s disease. “We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”
The Neuro’s drug discovery initiative aims to support research by developing assays that investigate different aspects of target cells and sharing these assays with colleagues around the world. The main vehicle for sharing assays is The Neuro’s Induced Pluripotent Stem Cell (iPSC) platform, developed recently with seed money generously donated by Sebastian van Berkom and Ghislaine Saucier.
“We can provide industry-standard assays researchers can use to test compounds,” says Thomas Durcan, another Parkinson’s researcher who manages the iPSC platform. “In collaboration with researchers at Université Laval, we reprogram blood cells from patients with neurological diseases into stem cells, and then transform the stem cells into the type of neural cells most impacted in neuropathology.”
This gives researchers the ability to compare normal and diseased states of the cells within one patient, which has long been possible for some diseases but is a novel advance for neurological research. The Centre for Drug Research and Development, a Canadian nonprofit organization that aims to speed the translation of discoveries into therapies, and the international Structural Genomics Consortium have both formed partnerships with the Tanenbaum Open Science Institute to use the iPSC platform.
“If we can identify potential compounds for targeting diseases such as Parkinson’s and share them so they can be screened and tested throughout the scientific community, we can accelerate the rate of discovery,” says Dr. Fon. “Other researchers can benefit from the resources we develop, and the chances of 100 laboratories finding something useful is much greater than that of one lab working alone. If we can come up with something leading to treatment for Parkinson’s disease, that would be an incredible payback.”
Learn more: Accelerating drug discovery with Open Science
The Latest on: Open Science
The Latest on: Biomechanics
via Google News
The Latest on: Open Science
- TACC Announces Results of Top500 List, First Large-Scale Science Runs, Fellowships at SC19on November 18, 2019 at 11:23 am
TACC also announced the launch of the Frontera Computational Science Fellowships, a year-long opportunity for talented Ph.D. students to compute on the most powerful academic supercomputer in the ...
- In its 15th year, INCITE advances open science with supercomputer grants to 47 projectson November 18, 2019 at 9:11 am
Jointly managed by the DOE's Leadership Computing Facilities at Argonne National Laboratory and Oak Ridge National Laboratory, INCITE is the primary means by which the facilities fulfill their mission ...
- All Saints Day School Open Science Morningon November 15, 2019 at 9:00 am
Third Grade students at All Saints Day School used the design process to explore ways to tackle environmental problems. During Open Science Morning, these students shared their recommendations for ...
- World Science Day: International Nuclear Information System Highlights Open Accesson November 8, 2019 at 2:46 am
In line with the theme of this year’s World Science Day for Peace and Development—“Open Science, leaving no one behind”—on 10 November, INIS plays a vital role in providing open access to information ...
- Royal Society Open Scienceon November 3, 2019 at 4:00 pm
Thousands of years ago, the inhabitants of modern-day Florida and the Caribbean feasted on sea turtles, leaving behind bones that tell tales of ancient diets and the ocean's past.
- Supercharge your research: a ten-week plan for open data scienceon October 31, 2019 at 12:44 pm
Despite the collaborative nature of scientific research, a key component — data analysis — can be a lonely burden. Undertaken by researchers who largely lack formal training in data and open science, ...
- Royal Society Open Scienceon October 29, 2019 at 5:00 pm
Royal Society Open Science is a new open journal publishing high-quality original research across the entire range of science on the basis of objective peer-review. The journal covers the entire range ...
- Open science has roots in the synthetic biology community, but we can do betteron October 23, 2019 at 4:11 am
Open science practices is a way to counter the reproducibility practices. By being open and transparent, research studies can be scrutinized and revisited to correct honest oversights, while ...
- Finnish Museum of Natural History receives University of Helsinki Open Science Awardon October 20, 2019 at 5:00 pm
The first University of Helsinki Open Science Award was granted in 2017. This year, the Award jury wanted to place special emphasis on the role of faculties and research-focused independent institutes ...
- Open Science Needs A Do-Overon October 20, 2019 at 5:00 pm
"We don't need more science but more just science," he argues, where transparency, replication and trial registration are the norm. "Open is not something that can be built on broken science." ...
via Bing News